Gastroesophageal Reflux: all 1,086 studies
Page 10 of 11. Open to participants first (187), then studies with results posted, then the rest; newest registration first within each.
- The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease QuestionnaireCompletedNCT00901004
- Diagnostic Efficacy of Narrow Band Imaging in Patients With Gastroesophageal Reflux DiseaseCompletedNCT00886197
- PillCam® ESO 2 in Esophageal PathologiesCompletedNCT00885469
- Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and ProductivityCompletedNCT00884247
- Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD)CompletedNCT00872755Phase 4
- Pepsin As A Biomarker For AspirationCompletedNCT00865995
- Twice Daily Prevacid for the Treatment of Laryngopharyngeal RefluxCompletedNCT00864396Phase 1
- Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD TreatmentTerminatedNCT00857597Phase 3
- A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD)CompletedNCT00855361Phase 1
- Laparoscopic Nissen Fundoplication Comparing Division Versus Non-Division of Short Gastric VesselsCompletedNCT00852098Not applicable
- Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in FranceCompletedNCT00842855
- Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)CompletedNCT00842387
- A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux DiseaseCompletedNCT00838396Phase 2
- National Survey on GERD Patients (Adults and Children)CompletedNCT00833573
- Study of Endoscopic Versus Open Surgery for Urinary RefluxWithdrawnNCT00830479Not applicable
- ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)CompletedNCT00820079Phase 2
- Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pHCompletedNCT00818870Phase 1
- Efficacy of Endoscopic Subureteral Injection for Vesicoureteral Reflux in Adults With Decreased Bladder ComplianceCompletedNCT00815334Not applicable
- ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)CompletedNCT00810485Phase 2
- Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the USCompletedNCT00795093
- Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.CompletedNCT00786773
- Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCPCompletedNCT00786695Not applicable
- Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal RefluxWithdrawnNCT00771706Phase 3
- Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)CompletedNCT00768443
- Prevalence of EED and Quality of Life Evaluated by Gastroesophageal Reflux Disease (GERD)-Q in Korean GERD PatientsCompletedNCT00768196
- AZD3355 Dose-escalation Study in Healthy MalesCompletedNCT00757419Phase 1
- A Pharmacokinetic and Safety Study of Single and Multiple Doses of Rabreprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Years Old, InclusiveCompletedNCT00747695Phase 1
- A Study of Single and Multiple Doses of Rabeprazole in Pediatric Patients With Gastroesophageal Reflux Disease (GERD) 1 to 11 Months Old, InclusiveCompletedNCT00747526Phase 1
- Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and InfantsCompletedNCT00744419Phase 1
- Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)TerminatedNCT00730665Phase 2
- Endoscopic Findings in Patients With Typical Gastroesophageal Reflux Disease (GERD) SymptomsCompletedNCT00730106
- Role of Mosapride in Patients With Gastroesophageal Reflux DiseaseCompletedNCT00729339Phase 4
- Waist Circumference Versus Body Mass Index to Predict Severity of Gastroesophageal Reflux DiseaseCompletedNCT00698178
- The Prevalence of Gastro-oesophageal Reflux in Chronic Lung DiseaseCompletedNCT00697177
- National Survey on Gastroesophageal Reflux Disease (GERD) PatientsCompletedNCT00695838
- Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) UseCompletedNCT00691171
- Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient SegmentsCompletedNCT00688675
- Study to Compare Different Formulations of AZD3355CompletedNCT00688402Phase 1
- Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)CompletedNCT00687245Phase 1
- Drug Interaction Study Between AZD3355 and NexiumCompletedNCT00684190Phase 1
- Prevalence of Gastroesophageal Reflux During Childhood and Teenage Years in FranceCompletedNCT00681837
- Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.CompletedNCT00674245Phase 2/3
- Quality of Life Validation in LaryngitisCompletedNCT00641264Phase 4
- Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)CompletedNCT00637845Phase 4
- Open, Randomized, Two Way Crossover 40mg, Orally and IntravenouslyCompletedNCT00635414Phase 4
- Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice WorkflowCompletedNCT00634608Not applicable
- Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERDCompletedNCT00634023
- An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00629564Phase 4
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)CompletedNCT00628342Phase 4
- A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00626535Phase 3
- Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and ivCompletedNCT00626262Phase 4
- Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)CompletedNCT00625495Phase 4
- Effect of Antireflux Therapy on the Expression of Genes in Patients With GERDTerminatedNCT00624546
- Patient Education in Gastroesophageal Reflux DiseaseCompletedNCT00618150Not applicable
- Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment PeriodCompletedNCT00614536
- Registry Study of the NDO Surgical Plicator for the Treatment of GERDTerminatedNCT00597792Not applicable
- A Study to Evaluate the Role of Alternative Medicine in Difficult to Treat GERD PatientsWithdrawnNCT00591877Not applicable
- Confocal Laser Microscopy in Non Erosive Reflux DiseaseCompletedNCT00588939
- Study of the NDO Endoscopic Plication System For the Treatment of Symptomatic Gastroesophageal Reflux DiseaseCompletedNCT00587522Not applicable
- Endoscopic Full-Thickness Plication for the Treatment of GERD: Long-Term Multicenter ResultsCompletedNCT00587392
- Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPITerminatedNCT00587275Phase 2
- Nasopharyngeal 24 Hour pH Monitoring in Health Adult VolunteersWithdrawnNCT00584675Not applicable
- Demographics and Findings of Upper Endoscopy PatientsTerminatedNCT00576992
- Novel Imaging Techniques in Barrett's EsophagusCompletedNCT00576498Not applicable
- A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERDTerminatedNCT00575822Not applicable
- Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected PatientsCompletedNCT00574925Phase 4
- LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)CompletedNCT00567619
- German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-SymptomsCompletedNCT00567021
- SThe Effects of Melatonin on GERD SymptomsStatus unknownNCT00564590Phase 1/2
- An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERDCompletedNCT00557401Phase 2
- Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.CompletedNCT00553449Phase 3
- Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.CompletedNCT00551473Phase 1
- Impact of GERD on Daily Life (NIS)CompletedNCT00545883
- The Proton Pump Inhibitor (PPI) Test for the Extraesophageal Manifestation of GERDStatus unknownNCT00539786Not applicable
- Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted DosingTerminatedNCT00537732Phase 4
- What is the Predictive Value of the Reflux Impact ScaleTerminatedNCT00536328
- Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in ChildrenCompletedNCT00521703Phase 3
- Do Patients Who Have Had Surgery for Achalasia Suffer From RefluxCompletedNCT00519441Not applicable
- Assessing Outcomes After Surgery for Gastroesophageal Reflux DisorderStatus unknownNCT00518505Not applicable
- A Study of the Use of High-dose Proton Pump Inhibitor for the Treatment of Gastro-oesophageal Reflux Related Non-cardiac Chest Pain - a Randomized Double-blind Placebo-controlled StudyStatus unknownNCT00517270Not applicable
- Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese PatientsCompletedNCT00517114Not applicable
- The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese PopulationStatus unknownNCT00516971Not applicable
- Barrett's Esophagus & Gastroesophageal Reflux DiseaseCompletedNCT00513331
- Influence of Hygiene-dietetic Habits and Treatment Adherence on the Effectiveness of the Gastroesophageal Reflux Illness Treatment With RabeprazolTerminatedNCT00511966
- Safety of Rabeprazole in Patients Under Multiple TreatmentsTerminatedNCT00511745
- Foreshortened Esophagus and Its Surgical TherapyCompletedNCT00507377
- Determinants of Efficacy of EsophyX Treatment in Gastro-Esophageal Reflux DiseaseStatus unknownNCT00498082
- Coordination Versus Pressure in Oesophageal PeristalsisCompletedNCT00482885
- Assessment of Gastro-esophageal Reflux Using Endo-Flip vs BravoCompletedNCT00481949
- A Prospective Randomized Trial Comparing Laparoscopic Nissen Against Anterior Partial Fundoplication in Treating Gastroesophageal Reflux Disease Among Chinese PatientsStatus unknownNCT00480285Phase 3
- Evaluation of Patients With Non-cardiac Chest PainCompletedNCT00476398Phase 4
- Esomeprazole and Gastric Emptying of BeerCompletedNCT00472550Phase 4
- The Influence of Hypnotic Medications on Sleep Arousal and Its Effect on Gastroesophageal RefluxCompletedNCT00462137
- High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux DiseaseCompletedNCT00461604
- GI Reflux in Lung Transplant and Its Relationship to Chronic RejectionCompletedNCT00455078
- Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal RefluxTerminatedNCT00451841
- The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)TerminatedNCT00449813Phase 4
- Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid SuppressionTerminatedNCT00444236Phase 1
- Novel Biomarkers in the Neoplastic Progression of Barrett's EsophagusActive, not recruitingNCT00431756
- Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal RefluxCompletedNCT00414856Phase 1